LLY · Eli Lilly and Company
1161.00
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$1.08T
PE
46.80
EV/EBITDA
31.6
DIV Yield
0.6%
Payout Ratio
26%
MQV Rating
2Strong
As at 21/07/2026 10:36:01 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Engulfing Bearish
- HALO 200
- HALO 50
- HALO 500
- HALO All
- HALO Capital Efficiency
- Recent Price upgrade
Key Fundamentals
EPS 3 yr Growth
232.10%
EBITDA Margin
48.60%
Operating Cashflow
$16,813m
Free Cash Flow Return
30.20%
ROIC
37.10%
Interest Coverage
N/A
Quick Ratio
1.20
Performance
52 weeks range
Low 623.78 - 1249.45
Trade Value (12mth)
US$840,866,581.00
1 week
-0.8%
1 month
6.04%
YTD
9.14%
1 year
52.79%
All time high
1249.45
Additional Data
Shares Outstanding (Fully Diluted)
1,106m
HALO Sector
Healthcare
Next Company Report Date
10-Feb-27
Next Ex Dividend Date
14-Aug-26
Next Dividend Pay Date
10-Sep-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Strong
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Strong
Earnings
Neutral
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Strong
Valuation
News & Announcements
| Date | Event |
24 June 26EDG | |
21 May 26EDG | |
21 May 26EDG | |
08 May 26EDG | |
08 May 26EDG |